News

Study reveals that high-grade serous carcinoma, the most aggressive form of ovarian cancer, originates from pre-ciliated tubal epithelial cells in the fallopian tube. This research provides insights into potential diagnostic and therapeutic targets.

Researchers have developed an immunotherapy for advanced Hodgkin lymphoma that increased survival rates to 92 percent. This innovative approach reduces long-term side effects associated with traditional treatments.

Researchers have created engineered probiotic bacteria that educate the immune system to attack cancer cells, showing promising results in mouse models. These personalized bacterial vaccines could lead to effective treatments for advanced cancers.

A study reveals that Conatumumab, an existing drug used for cancer treatment, can grow new blood vessels to bypass blockages in patients with Peripheral Artery Disease (PAD). This discovery may lead to significant advancements in treating PAD.

Research reveals that higher concentrations of extrachromosomal DNA (ecDNA) in aggressive tumors may aid cancer survival, marking it as a potential target for therapies. The study found ecDNA more prevalent in previously treated patients.

A short course of chemotherapy before chemoradiation extends cancer-free survival in cervical cancer patients, a new study finds.

A study reveals that CRISPR gene editing can disable a mutation in melanoma cells that leads to treatment resistance. By targeting the NRAS gene mutation, researchers restored the cells' sensitivity to anticancer drugs.

In a new study, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.

A new study reveals that gastric cancer patients treated with zolbetuximab live longer.

Researchers have established the English National Lynch Syndrome Registry, the UK’s first comprehensive database for patients with Lynch syndrome. This initiative links genomic data with cancer diagnosis and treatment information.